Stock SANOFI SANOFI INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sanofi India Limited NSE India S.E.

Equities

SANOFI

INE058A01010

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:49 2024-04-26 am EDT 		5-day change 1st Jan Change
8,274 INR +1.48% Intraday chart for Sanofi India Limited +0.18% +2.56%
Apr. 15 Sanofi India Limited Announces Appointment of Flovie Martins as Head of Corporate Communications and Corporate Social Responsibility CI
Mar. 28 Sanofi India Limited Announces Resignation of Marc-Antoine Lucchini as Non-Executive Director from the Board of Directors, Member of the Nomination and Remuneration Committee CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 146,307 161,572 191,565 181,781 134,721 190,650 190,650 -
Enterprise Value (EV) 1 146,307 161,572 191,565 181,781 134,721 185,790 190,650 190,650
P/E ratio 38.4 x 39 x 40.1 x 19.2 x 21.7 x 30.8 x 29.7 x 26.3 x
Yield 1.32% 1.51% 4.39% 6.21% 9.74% 4.19% 2.19% 2.41%
Capitalization / Revenue 5.28 x 5.26 x 6.6 x 6.15 x 4.86 x 6.52 x 6.16 x 5.6 x
EV / Revenue 5.28 x 5.26 x 6.6 x 6.15 x 4.86 x 6.52 x 6.16 x 5.6 x
EV / EBITDA 23.5 x 24.3 x 26.9 x 23.8 x 19.1 x 23.1 x 21.5 x 19.3 x
EV / FCF 46.5 x 48 x 33.6 x 33.9 x 35.8 x 94.5 x 23.9 x 24.2 x
FCF Yield 2.15% 2.08% 2.97% 2.95% 2.79% 1.06% 4.18% 4.13%
Price to Book 6.58 x 6.61 x 9.03 x 8.16 x 10.5 x 18.3 x 15.2 x 12.6 x
Nbr of stocks (in thousands) 23,031 23,031 23,031 23,031 23,031 23,031 23,031 -
Reference price 2 6,353 7,016 8,318 7,893 5,850 8,278 8,278 8,278
Announcement Date 2/26/19 2/25/20 2/23/21 2/23/22 2/23/23 2/23/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 27,708 30,706 29,019 29,566 27,701 28,511 30,957 34,014
EBITDA 1 6,235 6,653 7,131 7,625 7,044 8,040 8,858 9,893
EBIT 1 5,208 5,654 6,309 6,958 6,625 7,644 8,450 9,488
Operating Margin 18.8% 18.41% 21.74% 23.53% 23.92% 26.81% 27.3% 27.89%
Earnings before Tax (EBT) 1 6,098 5,999 6,772 12,576 8,643 8,458 9,010 10,152
Net income 1 3,806 4,142 4,776 9,444 6,206 6,032 6,412 7,236
Net margin 13.74% 13.49% 16.46% 31.94% 22.4% 21.16% 20.71% 21.27%
EPS 2 165.5 179.8 207.4 410.1 269.5 261.9 278.6 314.5
Free Cash Flow 1 3,147 3,365 5,697 5,358 3,765 1,965 7,973 7,866
FCF margin 11.36% 10.96% 19.63% 18.12% 13.59% 6.89% 25.75% 23.13%
FCF Conversion (EBITDA) 50.47% 50.58% 79.89% 70.27% 53.45% 24.44% 90% 79.52%
FCF Conversion (Net income) 82.69% 81.24% 119.28% 56.73% 60.67% 32.58% 124.34% 108.72%
Dividend per Share 2 84.00 106.0 365.0 490.0 570.0 347.0 181.2 199.6
Announcement Date 2/26/19 2/25/20 2/23/21 2/23/22 2/23/23 2/23/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 6,866 7,203 7,251 7,891 7,545 6,879 7,070 6,993 6,919 6,719 7,365 7,263 7,006 7,111 7,627
EBITDA 1 1,922 1,670 1,894 2,471 1,988 1,272 1,945 1,611 1,819 1,669 2,299 2,141 1,924 2,022 2,358
EBIT - - - - - - - - - - - - - - -
Operating Margin - - - - - - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - - - - - - -
Net income - 1,230 - 1,783 5,298 904 2,384 1,204 1,824 1,309 - 1,783 1,536 1,620 1,767
Net margin - 17.08% - 22.6% 70.22% 13.14% 33.72% 17.22% 26.36% 19.48% - 24.55% 21.92% 22.78% 23.17%
EPS - - - 77.42 - - - - 56.84 - - - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 10/27/20 2/23/21 4/27/21 7/27/21 10/26/21 2/23/22 4/26/22 7/26/22 11/3/22 2/23/23 5/10/23 - - - -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 3,147 3,365 5,697 5,358 3,765 1,965 7,973 7,867
ROE (net income / shareholders' equity) 17.9% 17.8% 20.9% 26.6% 30% 51.5% 55% 51.3%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 965.0 1,062 921.0 968.0 555.0 442.0 545.0 659.0
Cash Flow per Share - - - - - - - -
Capex 1 592 758 414 230 222 343 683 627
Capex / Sales 2.14% 2.47% 1.43% 0.78% 0.8% 1.2% 2.2% 1.84%
Announcement Date 2/26/19 2/25/20 2/23/21 2/23/22 2/23/23 2/23/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Sanofi India Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SANOFI Stock
  4. SANOFI Stock
  5. Financials Sanofi India Limited